# K022985: Ascendent Acetabular System

- Pathway: 510(k) (Traditional)
- Applicant: Sulzer Orthopedics, Inc.
- Decided: Dec 5, 2002 after 87 days
- Product code: LZO (Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented)
- Device class: 2
- Regulation: 21 CFR 888.3353
- Recalls of this device: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
1 later device descends from it; 1 cites it directly.
0 of 2 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names its predicate without a number.
- (no number) Sulzer Orthopedics Inter-Op Acetabular System: named in the summary without a submission number
- (no number) Sulzer Orthopedics Converge Acetabular System: named in the summary without a submission number
- (no number) Stryker Osteonics Howmedica System 12 Acetabular System: named in the summary without a submission number

## Most influential descendants
- K032348: Converge Reti-Lock Multi-Hole Reinforcement Cup (2003), 0 descendants of its own

## Recalls of this device
- Sep 30, 2003 · Not classified · Z-0809-04: Compalints of acetabular shell disassociating with the bone.

## Indications for use
Components of the Ascendant Acetabular System are intended for use in total hip arthroplasty for treatment of the following: 1. Patient conditions of noninflammatory degenerative joint disease (NIDJD), e.g., avascular necrosis, osteoarthritis, and inflammatory joint disease (IJD), e.g., rheumatoid arthritis. 2. Those patients with failed previous surgery where pain, deformity, or dysfunction persists. 3. Revision of previously failed hip arthroplasty.

Source page: https://510kreport.com/device/K022985
Methodology: https://510kreport.com/methodology